Oil Refiner Profits Will Miss the Mark
Wednesday, October 10th, 2007Months after record profits, oil refiners are being squeezed as their slow season coincides with record crude prices
Original post by AnthonyK
Months after record profits, oil refiners are being squeezed as their slow season coincides with record crude prices
Original post by AnthonyK
S&P thinks the oil and gas exploration and production outfit can achieve double-digit earnings and cash-flow growth over the next several years
Original post by AnthonyK
With 25 million Americans suffering from chronic insomnia, new treatments in the pipeline could find a huge market
Original post by AnthonyK
Initiatives to extend health insurance could especially benefit health-care facilities. S&P’s top pick: Psychiatric Solutions
Original post by AnthonyK
No accidents since 1979, environmental concerns over coal and gas, what’s not to like about nukes? Here are some ways to play the new interest
Original post by AnthonyK
S&P likes the fundamentals and "strong" management team of the behavioral health-services outfit, giving the stock its highest rating
Original post by AnthonyK
This degenerative brain disease will claim even more victims in the coming decades. Drug companies are racing to improve treatments and find a vaccine
Original post by AnthonyK
Ten energy and IT stocks shine this week after ranking with S&P’s proprietary qualitative and quantitative ranking methodologies
Original post by AnthonyK
Standard & Poor’s likes the generic drugmaker’s strong pipeline and global presence, and rates the shares a strong buy
Original post by AnthonyK
S&P says the group’s fundamentals are solid and its stock price momentum has improved. Among the top plays: Noble
Original post by AnthonyK